Cytokinetics, Inc. (CYTK)
55.05
-0.09
(-0.16%)
USD |
NASDAQ |
Nov 10, 09:42
Cytokinetics Cash and Short Term Investments (Quarterly) : 1.133B for Sept. 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.133B |
| June 30, 2026 | 1.169B |
| March 31, 2026 | 821.66M |
| December 31, 2025 | 885.34M |
| September 30, 2025 | 965.65M |
| June 30, 2025 | 859.75M |
| March 31, 2025 | 938.59M |
| December 31, 2024 | 1.076B |
| September 30, 2024 | 1.012B |
| June 30, 2024 | 1.057B |
| March 31, 2024 | 619.34M |
| December 31, 2023 | 615.20M |
| September 30, 2023 | 539.61M |
| June 30, 2023 | 566.10M |
| March 31, 2023 | 665.56M |
| December 31, 2022 | 782.58M |
| September 30, 2022 | 867.66M |
| June 30, 2022 | 586.03M |
| March 31, 2022 | 608.97M |
| December 31, 2021 | 471.64M |
| September 30, 2021 | 477.64M |
| June 30, 2021 | 350.30M |
| March 31, 2021 | 425.58M |
| December 31, 2020 | 464.06M |
| September 30, 2020 | 410.26M |
| Date | Value |
|---|---|
| June 30, 2020 | 213.06M |
| March 31, 2020 | 220.71M |
| December 31, 2019 | 225.11M |
| September 30, 2019 | 166.04M |
| June 30, 2019 | 172.87M |
| March 31, 2019 | 176.62M |
| December 31, 2018 | 198.73M |
| September 30, 2018 | 210.31M |
| June 30, 2018 | 231.94M |
| March 31, 2018 | 251.45M |
| December 31, 2017 | 268.89M |
| September 30, 2017 | 307.57M |
| June 30, 2017 | 312.05M |
| March 31, 2017 | 206.56M |
| December 31, 2016 | 156.25M |
| September 30, 2016 | 78.61M |
| June 30, 2016 | 90.34M |
| March 31, 2016 | 103.42M |
| December 31, 2015 | 111.44M |
| September 30, 2015 | 97.98M |
| June 30, 2015 | 105.18M |
| March 31, 2015 | 107.87M |
| December 31, 2014 | 83.23M |
| September 30, 2014 | 78.50M |
| June 30, 2014 | 77.75M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| BridgeBio Pharma, Inc. | 1.539B |
| Alnylam Pharmaceuticals, Inc. | 3.587B |
| BioMarin Pharmaceutical, Inc. | 736.01M |
| Exelixis, Inc. | 892.02M |
| Ionis Pharmaceuticals, Inc. | 1.884B |